Merit Medical Systems, Inc.
MMSI
Positions held
Your positionsMMSI isn't in your positions.
Add it to see shares, cost, and P&L here.
Bull / bear case
Site-generated summary from fundamentals, news, and score — not investment advice. As of 2026-10-08.
- Merit Medical Systems operates in a growing healthcare sector, focusing on innovative medical instruments and supplies that cater to increasing global healthcare demands.
- Revenue increased by 10% compared to the prior quarter, reaching $419 million.
- Gross margin improved to 51.4%, up from 48.4% in the previous quarter.
- The company's current market cap of approximately $5.07 billion may face pressure from increasing competition in the medical instruments industry.
- The trailing P/E ratio is 34.96, indicating that the stock may be overvalued compared to its earnings growth.
- The overall score remains neutral at 2.00, with bearish indicators such as a declining MACD and falling relative strength.
Fundamentals
| Market cap | $5.09B | Enterprise value | $5.46B | Trailing P/E | 35.08 | Forward P/E | 18.49 |
| PEG | 1.54 | Price / book | 3.03 | Beta | 0.51 | Dividend yield | 0.00% |
| Revenue growth | 9.5% | Earnings growth | 20.4% | Gross margin | 49.5% | Operating margin | 14.5% |
| Profit margin | 9.2% | ROE | 9.2% | ROA | 4.9% | Debt / equity | 0.49 |
| Current ratio | 4.20 | Free cash flow | $173.90M | Analyst recommendation | buy | Mean target | $101.45 |
| 52w high | $94.75 | 52w low | $59.74 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | |
|---|---|---|---|---|---|
| Revenue | $419M | $382M | $394M | $384M | $382M |
| Op margin | 14.5% | 11.5% | 13.7% | 11.1% | 12.3% |
| Net income | $38.8M | $41.0M | $38.0M | $27.8M | $32.6M |
| Gross margin | 51.4% | 48.4% | 49.6% | 48.5% | 48.2% |
| Gross profit | $215M | $185M | $195M | $186M | $184M |
| Operating income | $60.5M | $44.0M | $54.0M | $42.6M | $47.0M |
- Revenue +10% vs prior quarter ($419M vs $382M).
- Gross margin 51.4% (was 48.4% prior quarter).
- Operating margin expanded to 14.5%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $1.5B | $1.4B | $1.3B | $1.2B | — |
| Op margin | 12.3% | 11.5% | 10.1% | 8.8% | — |
| Net income | $128M | $120M | $94.4M | $74.5M | — |
| Gross margin | 48.7% | 47.4% | 46.4% | 45.1% | — |
| Gross profit | $738M | $643M | $584M | $519M | — |
| Operating income | $186M | $156M | $127M | $101M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-08 · Reasons to Retain Hims & Hers Stock in Your Portfolio for Now
2026-10-08 · 10x Genomics & Fred Hutch Join Forces on Cancer Biomarker Research
2026-10-07 · Reasons to Retain Fresenius Medical Stock in Your Portfolio for Now
2026-10-06 · Merit Medical Systems to Announce Third Quarter 2026 Results on October 29, 2026
2026-10-06 · HSIC or MMSI: Which Is the Better Value Stock Right Now?
2026-10-06 · Here's Why You Should Add Merit Medical Stock to Your Portfolio Now
2026-10-06 · Reasons to Retain Cardinal Health Stock in Your Portfolio for Now
2026-10-02 · Zacks Industry Outlook Highlights McKesson, Cardinal Health, Becton, Dickinson, Merit Medical Systems and ProDex
2026-10-01 · 5 Medical Dental Supply Stocks to Watch as Industry Prospects Improve
2026-09-28 · 1 Profitable Stock to Own for Decades and 2 We Brush Off
2026-09-21 · 2 Reasons to Sell MMSI and 1 Stock to Buy Instead
2026-09-11 · 1 Small-Cap Stock on Our Watchlist and 2 We Find Risky
Price (daily)
Full chart · RSI · MACD · patterns